Did Paulson Investments, through Michael McGinley or any other of its Registered Representatives, recommend the purchase of AspenBio Pharma, Inc., for your portfolio? Levin, Papantonio is investigating whether these recommendations were made based on inside information, and whether the information provided by Paulson Investments was accurate.
If you purchased AspenBio Phamra, Inc. based on the recommendations of Paulson Investments and its representatives, you may have a claim against your brokerage firm. Investors who relied on Paulson Investments to construct their portfolios and who held AspenBio Pharma may be entitled to recover their losses. Please contact Peter Mougey at Levin, Papantonio to explore your potential claim.
Wolves in Sheep’s Clothing The SEC has issued an update of a previous alert warning investors of scammers posing as SEC employees soliciting personal and financial information. In the warning, the SEC reminds the public that it does not allow financial solicitation offers, offer assistance in the sale or purchase of securities, or endorse money [...]